Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Radiation Therapy
  •  Hormone Therapy
  •  Thoracic Oncology
  •  Lymphoma
  •  Chemoprevention
  •  Immunology
  •  Paediatric Cancers
  •  Pancreatic Cancer


Citation: Clin Oncol. 2020;5(1):1680.DOI: 10.25107/2474-1663.1680

First Successful Experience of Organ-Preserving Endoscopic Surgical Treatment for Upper Urinary Tract Urothelial Carcinoma

Andrej D Kaprin, Dmitrij S Merinov, Dmitrij A Roshchin, Aleksandr A Kachmazov, Stanislav A Serebrianyi, Dmitrij V Perepechin, Shamil S Gurbanov, Dmitry S Blinov, Pavel S Pilchuk and Ekaterina V Blinova

Department of Onco-Urology, National Medical Research Centre Radiology, The Ministry of Health of the Russian Federation, Russia
Department of Research and Development, Care Mentor AI Russia,10, 2nd Tverskoy-Yamskoy Lane, Moscow, 125047, Russia
Department of Urology, RUDN University, Russia
Department of Operative Surgery and Clinical Anatomy, Sechenov University, Russia

*Correspondance to: Dmitry S Blinov 

 PDF  Full Text Research Article | Open Access


Objectives: To implement novel approach to endoscopic organ-preserving surgery of patients with urothelial cancer of the upper urinary tract and access the outcomes of such treatment.
Methods: A seventy-two-year-old male and five females aged from 53 to 68 with T1 low grade urothelial carcinoma of the renal pelvis and/or ureter, with no need for hemodialysis, and life expectancy more than 5 years were assigned to endoscopic surgery. Transcutaneous or retrograde holmium laser-assisted removal of the renal pelvis tumor was applied as surgical techniques. Postoperative follow-up period was at least 3 months and included ureteroscopy or transcutaneous pyeloscopy to check urodynamic disturbances, absence of the tumor relapse and progression, possible complications and hemodialysis needs. Results: The operation time was 30 min to 80 min and depended on tumor localization. In all cases, blood loss did not go beyond 200 ml. Acute Pyelonephritis as a complication of early postoperative period developed in one patient after transcutaneous removal of pelvis tumor. Over the observation time (3 to 24 months) after surgery we registered no needs for hemodialysis; no signs of tumor recurrence were detected. Conclusion: Organ-preserving endoscopic treatment of patients with UTUC may be considered as promising and alternative for conservative tactics due to providing local control on the tumor progression.


Urothelial carcinoma; Organ-preserving surgery; Upper urinary tract; Renal pelvis; Ureter

Cite the Article:

Kaprin AD, Merinov DS, Roshchin DA, Kachmazov AA, Serebrianyi SA, Perepechin DV, et al. First Successful Experience of Organ-Preserving Endoscopic Surgical Treatment for Upper Urinary Tract Urothelial Carcinoma. Clin Oncol. 2020;5:1680.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Removal of a Huge Uterine Mass, Weighing 11000 Grams, In an Elderly Woman with a Minimally Invasive Surgical Approach: Feasibility and Safety
 Abstract  PDF  Full Text
Molecular Pathological Signatures of Gastric Cancer in Koreans Revealed by Label-Free Proteomics
 Abstract  PDF  Full Text
View More...